About Gabrielle

Gabrielle Rich Aouad grew up in Switzerland where she graduated from Aiglon School. She graduated with honors from Oxford University in England, earning her B.A. in philosophy and modern languages. Fluent in five languages, Gabrielle was a champion skier, an expert in horseback riding and a skilled rock mountain climber.

In the summer of 1991, she moved to New York and joined the NYU intensive film program where she met her future husband, Philip Aouad. At the tender age of 23, she was diagnosed with advanced stage Hodgkin’s disease. Her strength and feistiness never failed through months of painful treatment.

Our Inspiration

Over two decades of funding

Helping to improve the efficacy of cancer treatments, reduce their toxicity and improve the quality of life of patients.

The Foundation funds innovative clinical or basic science research that will lead to novel therapeutic approaches that could replace, or be used in combination with existing effective therapies for patients with leukemia and lymphoma. Such therapeutic approaches could include alternative or complementary medicine.

More about what we do

Who We Fund

Gabrielle's Angel Foundation has awarded more than $41 million in research grants to the best and brightest scientists in America.

Our most recent grantees include: Dr Linde Miles of Cincinnati Children’s Medical Center; Dr. Francesca Ferraro of Washington University School of Medicine; Dr. Tania Jain of Johns Hopkins University; Dr. Jerry Lio from Ohio State University; Dr. David Beck of NYU Grossman School of Medicine and Dr. Zuzana Tothova of Dana-Farber Cancer Institute
Dr. Linde Miles, PhD
Dr. Linde Miles, PhD

Cincinnati Children’s Hospital Medical Center ,

Dr. Francesca Ferraro, MD, PhD
Dr. Francesca Ferraro, MD, PhD

Washington University School of Medicine ,

Dr. Tania Jain, MBBS
Dr. Tania Jain, MBBS

Johns Hopkins University,

Dr. Jerry Lio
Dr. Jerry Lio

Ohio State University,

Dr. David Beck
Dr. David Beck

NYU Grossman School of Medicine,

Dr. Zuzana Tothova
Dr. Zuzana Tothova

Dana-Farber Cancer Institute,

Medical Advisory Board

Eduardo D. Bruera, MD
Eduardo D. Bruera, MD

The University of Texas, MD Anderson Cancer Center

Michael A. Caligiuri, MD
Michael A. Caligiuri, MD

City of Hope National Medical Center

Curt I. Civin, MD
Curt I. Civin, MD

University of Maryland School of Medicine

John F. DiPersio, MD, PhD
John F. DiPersio, MD, PhD

Washington University School of Medicine

Jerome E. Groopman, MD
Jerome E. Groopman, MD

Harvard Institute of Medicine

Carl H. June, MD
Carl H. June, MD

University of Pennsylvania School of Medicine

Stephen D. Nimer, MD – Chairman
Stephen D. Nimer, MD – Chairman

Sylvester Comprehensive Cancer Center

Eirini Papapetrou, MD, PhD
Eirini Papapetrou, MD, PhD

Icahn School of Medicine at Mount Sinai

Rainer Storb, MD
Rainer Storb, MD

Fred Hutchinson Cancer Research Center

Sarah Tasian, MD
Sarah Tasian, MD

Children’s Hospital of Philadelphia (CHOP)

Jeffrey D. White, MD
Jeffrey D. White, MD

Bethesda, Maryland

*Janet D. Rowley, M.D., D.Sc.
*Barrie R. Cassileth, Ph.D.

Events & News

October 23, 2023

Angel Ball 2023

Gabrielle’s Angel Foundation for Cancer Research raised more than $3 million at Angel Ball on October 23rd at Cipriani Wall Street, hosted by co-founders, songwriter Denise Rich and her daughters Daniella Rich Kilstock and Ilona Rich Schachter. Click through for the full event recap!

Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Sarah Tasian

We are delighted to welcome former Gabrielle's Angel Foundation grantee Dr. Sarah Tasian to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research!

NEWS

2022 Research Grants

Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are $225,000 over a three year period.

Fiscal responsibility

By the Numbers

We take the commitment of our donors seriously. By showing fiscal responsibility in program, administrative and fundraising costs, 88 cents of every dollar we raise directly funds the future leaders of cancer research.